Micro Emerging Active

BMY Camzyos Phase 3 trial success

New narrative with limited coverage — still forming.

Score
0.4
Velocity
▲ 1.0
Articles
2
Sources
2

Sentiment Timeline

Event Timeline

Apr 09, 2026
Oxford BioTherapeutics Partners Bristol Myers Squibb On T-Cell Engager Therapies For Solid … Bullish
Apr 02, 2026
Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial … Neutral

Timeline

First SeenApr 02, 2026
Last UpdatedApr 02, 2026